Athanor Capital, LP Global Blood Therapeutics, Inc. Transaction History

Athanor Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $342,048 - $446,666	-8,784 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $330,717 - $560,155	8,784 New	8,784 $380,000
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $513,565 - $725,085	-9,734 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $474,337 - $796,435	9,734 New	9,734 $615,000
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $780,164 - $1.63 Million	-18,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $95,970 - $171,906	2,100 Added 12.65%	18,700 $1.49 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $752,810 - $961,306	16,600 New	16,600 $805,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.